Home
News
Your Voice
Links
Jobs
Sitemap
Contact
YOU ARE HERE: >
Kernow Clinical Commissioning Group
>
Formulary Information
>
Information Page
Home
Drugs
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Chapters
KCC Referral
Management System
Shared Care
Guidelines
Care Home
Resources
Local Resource
Packs
Chronic Pain
in Cornwall
Diabetes Resources
Respiratory Resources
Flu Resource Pack
Patient Group Direction (PGD)
Palliative Care Resources
Search
Search Drugs
Search BNF Categories
Notes
Click to View ALL BNF
Ch1 Gastro
Ch2 Cardio
Ch3 Respiratory
Ch4 CNS
Ch5 Infections
Ch6 Endocrine
Ch7 Obs & Gynae
Ch8 Malignant Disease
Ch9 Nutrition & Blood
Ch10 Muscuskeletal
Ch11 Eye
Ch12 Ear, Nose, Oropharynx
Ch13 Skin
Ch14 Immunological
Ch15 Anaesthesia
Ch19 Other Dugs
ch20 Dressings
ch21 Appliances
ch22 Incontinence appliances
ch23 Stoma appliances
>>
1. Drugs Used In Diabetes
2. Thyroid And Antithyroid Drugs
3. Corticosteroids (Endocrine)
4. Sex Hormones
5. Hypothalamic&Pituitary Hormones&Antioest
6. Drugs Affecting Bone Metabolism
7. Other Endocrine Drugs
>>
1. Short-Acting Insulins
2. Intermediate And Long-Acting Insulins
3. Hypodermic equipment
1. Sulfonylureas
2. Biguanides
3. Other Antidiabetics
0. Treatment Of Hypoglycaemia
0. Treatment of diabetic nephropathy and neuropathy
0. Screening and Monitoring Agents
(Click to View Drug List)
Cost
Cost
Packs
Packs
Items
Items
Loading…
Summary:
Formulary Notes (BNF Chapter)
Formulary Notes (BNF Chapter)
NICE Guidance (15)
NICE Guidance (15)
Other Links (5)
Other Links (5)
Important Local Documents (5)
Important Local Documents (5)
Notes for: Endocrine system
Last edited [17/05/2024 08:42:39]
NICE NG28 Type 2 diabetes in adults: management
NICE NG17 Type 1 diabetes in adults: diagnosis and management
NG18 Diabetes (type 1 and type 2) in children and young people
: diagnosis and management
Semaglutide
(
Ozempic)
setting
pre
-
set
quantities in
GP
pr
actice systems to prevent overprescribing
Guidelines for Blood Glucose Monitoring in Adults 2024
NICE Guidance (BNF Section Level) for - Drugs Used In Diabetes
15/07/2020
All NICE products (guidance etc.) on diabetes.
15/07/2020
PCOS metformin in women not planning pregnancy
12/05/2021
TA679 Dapagliflozin for treating chronic heart failure with reduced ejection fraction
13/05/2021
TA664 Liraglutide for managing overweight and obesity
20/09/2021
NG18 Diabetes (type 1 and type 2) in children and young people: diagnosis and management
20/09/2021
NG28 Type 2 diabetes in adults: management
20/09/2021
NG17 Type 1 diabetes in adults: diagnosis and management
15/03/2022
TA775 Dapagliflozin for treating chronic kidney disease
13/05/2022
TA773 Empagliflozin for treating chronic heart failure with reduced ejection fraction
28/06/2023
TA902 Dapagliflozin for treating chronic heart failure with preserved or mildly reduced ejection fraction
09/11/2023
TA929 Empagliflozin for treating chronic heart failure with preserved or mildly reduced ejection fraction
29/01/2024
Tirzepatide for treating type 2 diabetes NICE TA924
19/06/2024
TA942 Empagliflozin for treating chronic kidney disease
NICE Guidance (BNF Chapter Level) for - Endocrine system
16/08/2023
Semaglutide for managing overweight and obesity NICE TA875
09/08/2024
TA863 Somatrogon for treating growth disturbance in children and young people aged 3 years and over
Other links (BNF Section Level) for - Drugs Used In Diabetes
15/07/2020
SGLT2 inhibitors: updated advice on the risk of diabetic ketoacidosis
15/07/2020
Canagliflozin (Invokana, Vokanamet): signal of increased risk of lower extremity amputations observed in trial in high cardiovascular risk patients
15/07/2020
SGLT2 inhibitors: reports of Fournier’s gangrene (necrotising fasciitis of the genitalia or perineum)
15/07/2020
SGLT2 inhibitors: monitor ketones in blood during treatment interruption for surgical procedures or acute serious medical illness
30/09/2020
DSU Sept 2020 Insulins (all types): Risk of cutaneous amyloidosis at injection site
Important Local Documents (BNF Chapter Level) for - Endocrine system
23/10/2020
NHS Kernow lancets factsheet September 2020
19/11/2021
NHS Kernow home blood glucose testing leaflet October 2021
31/10/2022
Glucagon-like peptide-1 (GLP-1) analogue factsheet 2022
10/03/2023
Insulin needle factsheet Cornwall ICB
10/08/2020
NHS Kernow diabetes and frailty guidance June 2020
Loading…
Cornwall Joint Formulary Recommended Choices
(...Top)
Displaying 46 Drugs
Key:
First Line Drugs
Second Line Drugs
Specialist advised
Specialist Initiated Drugs
Hospital Only Drugs
Discouraged
No comment available
Name
Tariff
BNF Sub Paragraph
Ertugliflozin (Steglatro)
5 mg tablets Pack of 28
£29.40
Other Antidiabetics
Ertugliflozin as monotherapy or with metformin for treating type 2 diabetes as per NICE TA572
Tirzepatide (Mounjaro KwikPen)
2.5 mg/0.6ml solution for injection (2.4ml pre-filled pens) Pack of 1
£92.00
Other Antidiabetics
Tirzepatide can be initiated in primary care for people with type 2 diabetes as per NICE TA924 criteria. Secondary care virtual referrals may be used for patients with existing retinopathy or complex issues.
Tirzepatide (Mounjaro KwikPen)
5 mg/0.6ml solution for injection (2.4ml pre-filled pens) Pack of 1
£92.00
Other Antidiabetics
Tirzepatide can be initiated in primary care for people with type 2 diabetes as per NICE TA924 criteria. Secondary care virtual referrals may be used for patients with existing retinopathy or complex issues.
Tirzepatide (Mounjaro KwikPen)
7.5 mg/0.6ml solution for injection (2.4ml pre-filled pens) Pack of 1
£107.00
Other Antidiabetics
Tirzepatide can be initiated in primary care for people with type 2 diabetes as per NICE TA924 criteria. Secondary care virtual referrals may be used for patients with existing retinopathy or complex issues.
Tirzepatide (Mounjaro KwikPen)
10 mg/0.6ml solution for injection (2.4ml pre-filled pens) Pack of 1
£107.00
Other Antidiabetics
Tirzepatide can be initiated in primary care for people with type 2 diabetes as per NICE TA924 criteria. Secondary care virtual referrals may be used for patients with existing retinopathy or complex issues.
Tirzepatide (Mounjaro KwikPen)
12.5 mg/0.6ml solution for injection (2.4ml pre-filled pens) Pack of 1
£122.00
Other Antidiabetics
Tirzepatide can be initiated in primary care for people with type 2 diabetes as per NICE TA924 criteria. Secondary care virtual referrals may be used for patients with existing retinopathy or complex issues.
Tirzepatide (Mounjaro KwikPen)
15 mg/0.6ml solution for injection (2.4ml pre-filled pens) Pack of 1
£122.00
Other Antidiabetics
Tirzepatide can be initiated in primary care for people with type 2 diabetes as per NICE TA924 criteria. Secondary care virtual referrals may be used for patients with existing retinopathy or complex issues.
Pioglitazone
15 mg tab Pack of 28
£1.05
Other Antidiabetics
Repaglinide
0.5 mg tab Pack of 30
£1.22
Other Antidiabetics
Pioglitazone
30 mg tab Pack of 28
£1.33
Other Antidiabetics
Sitagliptin
25 mg tablets Pack of 28
£1.45
Other Antidiabetics
Pioglitazone
45 mg tab Pack of 28
£1.92
Other Antidiabetics
Sitagliptin
50 mg tablets Pack of 28
£2.14
Other Antidiabetics
Sitagliptin
100 mg tablets Pack of 28
£2.32
Other Antidiabetics
Repaglinide
1 mg tab Pack of 90
£9.45
Other Antidiabetics
Repaglinide
2 mg tab Pack of 90
£10.93
Other Antidiabetics
Alogliptin (Vipidia)
6.25 mg tablets Pack of 28
£26.60
Other Antidiabetics
Alogliptin (Vipidia)
12.5 mg tablets Pack of 28
£26.60
Other Antidiabetics
Alogliptin (Vipidia)
25 mg tablets Pack of 28
£26.60
Other Antidiabetics
Linagliptin (Trajenta)
5 mg tab Pack of 28
£33.26
Other Antidiabetics
Canagliflozin (Invokana)
100 mg tab Pack of 30
£39.20
Other Antidiabetics
May only be initiated in primary care for people with type 2 diabetes and no heart failure.
Canagliflozin (Invokana)
300 mg tab Pack of 30
£39.20
Other Antidiabetics
May only be initiated in primary care for people with type 2 diabetes and no heart failure.
Semaglutide (Ozempic)
0.25 mg /0.19ml solution for injection 1.5ml pre-filled disposable device Pack of 1
£73.25
Other Antidiabetics
Semaglutide (Ozempic)
0.5 mg /0.37ml solution for injection 1.5ml pre-filled disposable device Pack of 1
£73.25
Other Antidiabetics
Semaglutide (Ozempic)
1 mg /0.74ml solution for injection 3ml pre-filled disposable device Pack of 1
£73.25
Other Antidiabetics
Exenatide (Bydureon BCise)
2 mg/0.85ml prolonged-release suspension for injection pre-filled pens Pack of 4
£73.36
Other Antidiabetics
Liraglutide Injection (Victoza)
6 mg/ml 3ml prefilled pen Pack of 2
£78.48
Other Antidiabetics
Dapagliflozin (Forxiga)
5 mg tab Pack of 28
£36.59
Other Antidiabetics
Other Antidiabetics
May be initiated in primary care for people with type 2 diabetes and no heart failure and for use in the management of CKD as per NICE TA775. Dapagliflozin remains as specialist recommended in the treatment of chronic heart failure (with or without T2D) in line with NICE TA679. Please note - a starting dose of 5mg is only to be used in cases of severe hepatic impairment, this may be increased to 10mg if well tolerated.
Dapagliflozin (Forxiga)
10 mg tab Pack of 28
£36.59
Other Antidiabetics
Other Antidiabetics
May be initiated in primary care for people with type 2 diabetes and no heart failure and for use in the management of CKD as per NICE TA775. Dapagliflozin remains as specialist recommended in the treatment of chronic heart failure (with or without T2D) in line with NICE TA679. Please note - a starting dose of 5mg is only to be used in cases of severe hepatic impairment, this may be increased to 10mg if well tolerated.
Empagliflozin (Jardiance)
10 mg tab Pack of 28
£36.59
Other Antidiabetics
Other Antidiabetics
May be initiated in primary care for people with type 2 diabetes and no heart failure and for the managment of CKD in line with NICE TA 942. Empagliflozin remains as specialist recommended in the treatment of chronic heart failure (with or without T2D) - in line with NICE TA773 and TA929
Empagliflozin (Jardiance)
25 mg tab Pack of 28
£36.59
Other Antidiabetics
Other Antidiabetics
May be initiated in primary care for people with type 2 diabetes and no heart failure and for the managment of CKD in line with NICE TA 942. Empagliflozin remains as specialist recommended in the treatment of chronic heart failure (with or without T2D) - in line with NICE TA773 and TA929
Semaglutide (Rybelsus)
3 mg tabs Pack of 30
£78.48
Other Antidiabetics
Specialist initiated or advised only
Semaglutide (Rybelsus)
7 mg tabs Pack of 30
£78.48
Other Antidiabetics
Specialist initiated or advised only
Semaglutide (Rybelsus)
14 mg tabs Pack of 30
£78.48
Other Antidiabetics
Specialist initiated or advised only
Semaglutide (Wegovy FlexTouch)
0.25 mg/0.37ml solution for injection 1.5ml pre-filled pens Pack of 1
-
Other Antidiabetics
Prescribing to remain within secondary care specialist weight management service as per NICE TA 875
Semaglutide (Wegovy FlexTouch)
0.5 mg/0.37ml solution for injection 1.5ml pre-filled pens Pack of 1
-
Other Antidiabetics
Prescribing to remain within secondary care specialist weight management service as per NICE TA 875
Semaglutide (Wegovy FlexTouch)
1 mg/0.75ml solution for injection 3ml pre-filled pens Pack of 1
-
Other Antidiabetics
Prescribing to remain within secondary care specialist weight management service as per NICE TA 875
Semaglutide (Wegovy FlexTouch)
1.7 mg/0.75ml solution for injection 3ml pre-filled pens Pack of 1
-
Other Antidiabetics
Prescribing to remain within secondary care specialist weight management service as per NICE TA 875
Semaglutide (Wegovy FlexTouch)
2.4 mg/0.75ml solution for injection 3ml pre-filled pens Pack of 1
-
Other Antidiabetics
Prescribing to remain within secondary care specialist weight management service as per NICE TA 875
Liraglutide injection (Saxenda )
6 mg/ml solution for injection 3ml pre-filled pen Pack of 5
-
Other Antidiabetics
To be prescribed via specialist weight management service only
Sitagliptin / Metformin (Janumet)
50 mg / 1000mg tab Pack of 56
£33.26
Other Antidiabetics
Dulaglutide (Trulicity)
0.75 mg/0.5ml solution for injection pre-filled pen disposable injection Pack of 4
£73.25
Other Antidiabetics
Dulaglutide (Trulicity) is only to be prescribed for patients already on treatment. Please do not initiate new patients on this medication.
Dulaglutide (Trulicity)
1.5 mg/0.5ml solution for injection pre-filled pen disposable injection Pack of 4
£73.25
Other Antidiabetics
Dulaglutide (Trulicity) is only to be prescribed for patients already on treatment. Please do not initiate new patients on this medication.
Dulaglutide (Trulicity)
3 mg/0.5ml solution for injection pre-filled pen disposable injection Pack of 4
£73.25
Other Antidiabetics
Dulaglutide (Trulicity) is only to be prescribed for patients already on treatment. Please do not initiate new patients on this medication.
Dulaglutide (Trulicity)
4.5 mg/0.5ml solution for injection pre-filled pen disposable injection Pack of 4
£73.25
Other Antidiabetics
Dulaglutide (Trulicity) is only to be prescribed for patients already on treatment. Please do not initiate new patients on this medication.
Exenatide Injection (Byetta)
10 mcg/dose (250mcg/ml) (60 dose pfs) Pack of 1
£81.89
Other Antidiabetics
© Kernow Clinical Commissioning Group 2024 - All Rights Reserved
The Sedgemoor Centre, Priory Road, St Austell, Cornwall, PL25 5AS